Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: Denmark Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20095
20101
20121
20142
20151
20162
20181
20193
20201
20211
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting6
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
AbbVie2
Acerta Pharma BV2
Celgene2
Merck Sharp & Dohme LLC2
AstraZeneca1
BeOne Medicines1
CSL Behring1
European Organisation for Research and Treatment of Cancer - EORTC1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell25
Multiple Myeloma3
Agammaglobulinemia2
Hematologic Neoplasms2
Leukemia2
Leukemia, Myeloid, Acute2
Lymphoma, Non-Hodgkin2
Neoplasms2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Burkitt Lymphoma1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.